Innoveren Scientific Inc. Stock price

Equities

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 02:37:55 2024-03-28 pm EDT 5-day change 1st Jan Change
0.033 USD +17.86% Intraday chart for Innoveren Scientific Inc. -26.67% -71.55%
Sales 2021 1.61M Sales 2022 453K Capitalization 1.62M
Net income 2021 -4M Net income 2022 -10M EV / Sales 2021 7.95 x
Net Debt 2021 3.52M Net Debt 2022 3.92M EV / Sales 2022 12.2 x
P/E ratio 2021
-1.73 x
P/E ratio 2022
-0.08 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 35.62%
More Fundamentals * Assessed data
Dynamic Chart
Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt CI
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding CI
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding CI
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown. CI
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
H-CYTE, Inc. announced that it has received $0.225 million in funding CI
H-CYTE, Inc. (OTCQB: HCYT) entered into a letter of intent to acquire SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown for $2.3 million. CI
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc. CI
More news
1 day+17.86%
1 week-26.67%
Current month-16.88%
1 month+37.50%
3 months-82.45%
6 months-90.23%
Current year-71.55%
More quotes
1 week
0.02
Extreme 0.024
0.04
1 month
0.02
Extreme 0.02
0.08
Current year
0.02
Extreme 0.018
0.18
1 year
0.00
Extreme 0.0003
3.73
3 years
0.00
Extreme 0.0003
289.00
5 years
0.00
Extreme 0.0003
990.00
10 years
0.00
Extreme 0.0003
990.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 19-01-07
Director of Finance/CFO 48 19-02-03
Chief Tech/Sci/R&D Officer 64 20-06-14
Members of the board TitleAgeSince
Director/Board Member 65 22-01-16
Chief Executive Officer 53 19-01-07
Director/Board Member 70 18-10-08
More insiders
Date Price Change Volume
24-03-28 0.033 +17.86% 300,279
24-03-27 0.028 -0.25% 330,410
24-03-26 0.0281 +0.25% 339,952
24-03-25 0.028 -6.67% 59,465
24-03-22 0.03 -33.33% 130,479

Delayed Quote OTC Markets, March 28, 2024 at 02:37 pm EDT

More quotes
Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.
More about the company
  1. Stock
  2. Equities
  3. Stock Innoveren Scientific Inc. - OTC Markets